Subsequent Event - Additional Information (Detail) - USD ($) $ in Millions |
3 Months Ended | |
---|---|---|
May 07, 2019 |
Mar. 31, 2019 |
|
SWK Loan | ||
Subsequent Event [Line Items] | ||
Line of credit facility, maximum borrowing capacity | $ 12.5 | |
Debt instrument covenant description | (i) maintain unencumbered liquid assets of no less than $1.5 million or the sum of aggregate cash flow from operations less capital expenditures, ii) achieve certain revenue and EBITDA levels during the first two years of the loan, (iii) limit future borrowing, investments and dividends, and (iv) submit monthly and quarterly financial reporting. | |
Subsequent Event | SWK Warrants | ||
Subsequent Event [Line Items] | ||
Additional warrants to purchase common stock value | $ 0.3 | |
Subsequent Event | DPG Warrants | ||
Subsequent Event [Line Items] | ||
Additional warrants to purchase common stock value | 0.1 | |
Additional finders fee | 0.1 | |
Subsequent Event | SWK Loan | ||
Subsequent Event [Line Items] | ||
Line of credit facility, maximum borrowing capacity | 15.0 | |
Minimum level of liquidity financial covenant | 1.5 | |
Loan origination and other fees to be paid | $ 0.2 | |
Debt instrument covenant description | (a) adjust minimum revenue and EBITDA levels, (b) require the Company to have a shelf registration statement declared effective by the SEC before September 30, 2019, with a proposed maximum aggregate offering price of at least $10.0 million if the Company does not reach set minimum revenue levels for the three-month period ended June 30, 2019, and (c) require minimum liquidity of $1.5 million at all times and if aggregate minimum revenue and EBITDA levels are not achieved by September 30, 2019, the minimum liquidity requirement will be increased to $3.0 million, until the Company has obtained additional equity or debt funding of no less than $5.0 million. | |
Additional equity or debt funding requirement until minimum liquidity is met | $ 5.0 | |
Maximum aggregate offering price | 10.0 | |
Increase in minimum liquidity requirement if aggregate minimum revenue and EBITDA levels are not achieved | $ 3.0 |
X | ||||||||||
- Definition Additional equity funding requirement until minimum liquidity is met. No definition available.
|
X | ||||||||||
- Definition Additional warrants to purchase common stock value. No definition available.
|
X | ||||||||||
- Definition Debt instrument additional finders fee. No definition available.
|
X | ||||||||||
- Definition Debt instrument fee and other fee payable. No definition available.
|
X | ||||||||||
- Definition Debt instrument financial covenants increase in minimum liquidity requirement. No definition available.
|
X | ||||||||||
- Definition Debt instrument financial covenants minimum liquidity amount. No definition available.
|
X | ||||||||||
- Definition Debt instrument, maximum aggregate offering price. No definition available.
|
X | ||||||||||
- Definition Description of minimum financial levels (for example, tangible net worth and working capital) and achievement of certain financial ratios (for example, working capital ratio and debt service coverage ratio), and adherence to certain clauses which generally require or restrict certain actions (for example, entering into a debt arrangement with equal or greater seniority, and selling or discontinuing a certain business segment or material subsidiary) to be in compliance with the covenant clauses of the debt agreement. May also include a discussion of the adverse consequences that would result if the entity violates or fails to satisfy the covenants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|